J A Kemp has been ranked as a leading UK patent prosecution firm in “IAM Patent 1000 - The World’s Leading Professionals 2017”.
The directory says that J A Kemp “responds quickly, creatively and thoroughly, and is always professional and reliable”.
The directory makes the following recommendations of individual J A Kemp partners:
“An authority in the pharmaceutical field, Ravi Srinivasan has vast experience filing international applications and – as a qualified litigator – performs adroitly in opposition and appeal hearings before the EPO. He recently successfully defended Durect Corporation’s Relday anti-psychotic medication against an opposition filed by Mylan.”
“Getting into new matters very quickly, asking the right questions and developing effective strategies for opposition cases, Mark Roberts knows where weak spots might be and effectively balances what is relevant for a case and what can be kept at the side to prevent resource drain.”
“Technically knotty cases – such as a defence of Bristol Myers Squibb and Ono Pharmaceutical’s Opdivo immunotherapy treatment against four opposing parties – are in safe hands with biotechnology doyenne Sarah Roques, who has also cultivated an extensive opposition practice.”
“Simon Wright's 30 years in the game are invaluable for life sciences clients ranging from multinationals to embryonic academic organisations.”
“Mike Nicholls blazes a trail in the engineering and IT sectors.”
IAM Patent 1000 is Intellectual Asset Management’s (IAM’s) guide to leading private practice patent professionals and firms in the world’s key jurisdictions.